Harbourvest Partners’s Epizyme, Inc EPZM Stock Holding History

Harbourvest Partners’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-24,686	Closed	-$62K	–	77
2021 Q4	$62K	Hold	24,686	–	–	0.01%	65
2021 Q3	$126K	Hold	24,686	–	–	0.01%	55
2021 Q2	$205K	Hold	24,686	–	–	0.02%	47
2021 Q1	$215K	Hold	24,686	–	–	0.03%	39
2020 Q4	$268K	Hold	24,686	–	–	0.1%	22
2020 Q3	$295K	Hold	24,686	–	–	0.11%	29
2020 Q2	$396K	Buy	+24,686	New	+$431K	0.17%	21
2019 Q4	–	Sell	-14,098	Closed	-$145K	–	40
2019 Q3	$145K	Hold	14,098	–	–	0.06%	30
2019 Q2	$177K	Buy	+14,098	New	+$181K	0.06%	30
2016 Q1	–	Sell	-5,196	Closed	-$83K	–	28
2015 Q4	$83K	Hold	5,196	–	–	0.03%	23
2015 Q3	$67K	Hold	5,196	–	–	0.03%	21
2015 Q2	$125K	Hold	5,196	–	–	0.06%	20
2015 Q1	$98K	Hold	5,196	–	–	0.06%	16
2014 Q4	$98K	Buy	+5,196	New	+$121K	0.05%	29

Other funds holding EPZM

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Harbourvest Partners's EPZM Position: Q1 2022 in Review

Harbourvest Partners sold out of Epizyme, Inc (EPZM) in Q1 2022, closing a stake of 24,686 shares — an estimated $62K sold.

Harbourvest Partners first reported a position in EPZM in Q4 2014 and held it in 14 quarters. The position peaked at $396K in Q2 2020. 120 funds tracked by Wall St. Rank hold EPZM as of Q1 2022.

Harbourvest Partners reported no remaining Epizyme, Inc position as of Q1 2022 after selling out during the quarter.
Harbourvest Partners sold 24,686 Epizyme, Inc shares in Q1 2022, an estimated $62K.
Harbourvest Partners first reported a position in Epizyme, Inc in Q4 2014 and held it in 14 quarters.
Harbourvest Partners's Epizyme, Inc position peaked at $396K in Q2 2020.
120 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2022.

Based on Harbourvest Partners's 13F filing for Q1 2022, filed 13 May 2022.